New insights into the function of Interleukin-25 in disease pathogenesis

Abstract Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction...

Full description

Bibliographic Details
Main Authors: Qingfang Yuan, Na Peng, Fan Xiao, Xiaofei Shi, Bo Zhu, Ke Rui, Jie Tian, Liwei Lu
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-023-00474-9
_version_ 1797853675993956352
author Qingfang Yuan
Na Peng
Fan Xiao
Xiaofei Shi
Bo Zhu
Ke Rui
Jie Tian
Liwei Lu
author_facet Qingfang Yuan
Na Peng
Fan Xiao
Xiaofei Shi
Bo Zhu
Ke Rui
Jie Tian
Liwei Lu
author_sort Qingfang Yuan
collection DOAJ
description Abstract Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment.
first_indexed 2024-04-09T19:54:32Z
format Article
id doaj.art-c87cbdbb708c49868273debcecdf2c25
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-04-09T19:54:32Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-c87cbdbb708c49868273debcecdf2c252023-04-03T05:35:01ZengBMCBiomarker Research2050-77712023-04-0111111610.1186/s40364-023-00474-9New insights into the function of Interleukin-25 in disease pathogenesisQingfang Yuan0Na Peng1Fan Xiao2Xiaofei Shi3Bo Zhu4Ke Rui5Jie Tian6Liwei Lu7Institute of Medical Immunology, Affiliated Hospital of Jiangsu UniversityDepartment of Rheumatology, the Second People’s Hospital, Three Gorges UniversityDepartment of Pathology, Shenzhen Institute of Research and Innovation, The University of Hong Kong, Chongqing International Institute for ImmunologyDepartment of Rheumatology and Immunology, The First Affiliated Hospital, School of Medicine, Henan University of Science and TechnologyInstitute of Medical Immunology, Affiliated Hospital of Jiangsu UniversityInstitute of Medical Immunology, Affiliated Hospital of Jiangsu UniversityInstitute of Medical Immunology, Affiliated Hospital of Jiangsu UniversityDepartment of Rheumatology, the Second People’s Hospital, Three Gorges UniversityAbstract Interleukin-25 (IL-25), also known as IL-17E, is a cytokine belonging to the IL-17 family. IL-25 is abundantly expressed by Th2 cells and various kinds of epithelial cells. IL-25 is an alarm signal generated upon cell injury or tissue damage to activate immune cells through the interaction with IL-17RA and IL-17RB receptors. The binding of IL-25 to IL-17RA/IL-17RB complex not only initiates and maintains type 2 immunity but also regulates other immune cells (e.g., macrophages and mast cells) via various signaling pathways. It has been well-documented that IL-25 is critically involved in the development of allergic disorders (e.g., asthma). However, the roles of IL-25 in the pathogenesis of other diseases and the underlying mechanisms are still unclear. This review presents current evidence on the roles of IL-25 in cancers, allergic disorders, and autoimmune diseases. Moreover, we discuss the unanswered key questions underlying IL-25-mediated disease pathology, which will provide new insights into the targeted therapy of this cytokine in clinical treatment.https://doi.org/10.1186/s40364-023-00474-9IL-25(IL-17E)Autoimmune diseasesInflammationCancerClinical treatment
spellingShingle Qingfang Yuan
Na Peng
Fan Xiao
Xiaofei Shi
Bo Zhu
Ke Rui
Jie Tian
Liwei Lu
New insights into the function of Interleukin-25 in disease pathogenesis
Biomarker Research
IL-25(IL-17E)
Autoimmune diseases
Inflammation
Cancer
Clinical treatment
title New insights into the function of Interleukin-25 in disease pathogenesis
title_full New insights into the function of Interleukin-25 in disease pathogenesis
title_fullStr New insights into the function of Interleukin-25 in disease pathogenesis
title_full_unstemmed New insights into the function of Interleukin-25 in disease pathogenesis
title_short New insights into the function of Interleukin-25 in disease pathogenesis
title_sort new insights into the function of interleukin 25 in disease pathogenesis
topic IL-25(IL-17E)
Autoimmune diseases
Inflammation
Cancer
Clinical treatment
url https://doi.org/10.1186/s40364-023-00474-9
work_keys_str_mv AT qingfangyuan newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT napeng newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT fanxiao newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT xiaofeishi newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT bozhu newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT kerui newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT jietian newinsightsintothefunctionofinterleukin25indiseasepathogenesis
AT liweilu newinsightsintothefunctionofinterleukin25indiseasepathogenesis